Pricing Log in Create free account

Genelux Corporation (GNLX) vs PMV Pharmaceuticals, Inc. (PMVP)

Genelux Corporation and PMV Pharmaceuticals, Inc. are both Biotechnology companies. Genelux Corporation and PMV Pharmaceuticals, Inc. are of similar size ($94.4M and $93.7M). Across the 9 metrics below, PMV Pharmaceuticals, Inc. leads on 5 and Genelux Corporation on 4.

Valuation

Metric GNLX PMVP Biotechnology median
P/E n/m n/m 10.96
P/S 7.80 n/m 9.52
P/B 5.44 0.92 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m 0.17 0.68
EV/Sales 6.89 n/m 9.00
Earnings yield (44.10%) (115.45%) (32.09%)
Free cash flow yield (32.72%) (108.52%) (22.62%)

Profitability

Metric GNLX PMVP Biotechnology median
Gross margin (3.42%) 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (177.93%) (70.93%) (50.12%)
Return on assets (121.80%) (64.04%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNLX PMVP Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) 9.47% (29.82%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNLX PMVP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.39 7.70 4.74
Net debt to EBITDA 0.44 1.27 1.01

Dividend

Metric GNLX PMVP Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric GNLX PMVP Biotechnology median
Market cap 93.66m 94.39m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack